Cargando…

Bioactive multi-protein adsorption enables targeted mast cell nanotherapy

Detalles Bibliográficos
Autores principales:	Du, Fanfan, Rische, Clayton H., Li, Yang, Vincent, Michael P., Krier-Burris, Rebecca A., Qian, Yuan, Yuk, Simseok A., Almunif, Sultan, Bochner, Bruce S., Qiao, Baofu, Scott, Evan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Journal Experts 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9901012/ https://www.ncbi.nlm.nih.gov/pubmed/36747749 http://dx.doi.org/10.21203/rs.3.rs-2468299/v1

Ejemplares similares

Interactions between Siglec-8 and endogenous sialylated cis ligands restrain cell death induction in human eosinophils and mast cells
por: Cao, Yun, et al.
Publicado: (2023)

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
por: Robida, Piper A., et al.
Publicado: (2022)

Nanomedicine‐Enabled/Augmented Cell Pyroptosis for Efficient Tumor Nanotherapy
por: Zhang, Zheng, et al.
Publicado: (2022)

The role of high-resolution imaging in the evaluation of nanosystems for bioactive encapsulation and targeted nanotherapy
por: Khosravi-Darani, Kianoush, et al.
Publicado: (2007)

Dendritic peptide-conjugated polymeric nanovectors for non-toxic delivery of plasmid DNA and enhanced non-viral transfection of immune cells
por: Yi, Sijia, et al.
Publicado: (2022)

Tumor Microenvironment Targeted Nanotherapy
por: Fernandes, Clara, et al.
Publicado: (2018)

Imaging-assisted anticancer nanotherapy
por: Dasgupta, Anshuman, et al.
Publicado: (2020)

Prediction of Anti-cancer Nanotherapy Efficacy by Imaging
por: Miller, Miles A., et al.
Publicado: (2017)

Ormeloxifene nanotherapy for cervical cancer treatment
por: Chauhan, Neeraj, et al.
Publicado: (2019)

Antioxidant Nanotherapies for the Treatment of Inflammatory Diseases
por: Li, Chen-Wen, et al.
Publicado: (2020)

Potential Targeting of Siglecs, Mast Cell Inhibitory Receptors, in Interstitial Cystitis
por: Park, Chang-Shin, et al.
Publicado: (2011)

Allergic inflammation is initiated by IL-33–dependent crosstalk between mast cells and basophils
por: Hsu, Chia-Lin, et al.
Publicado: (2020)

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy
por: Pérez-Medina, Carlos, et al.
Publicado: (2016)

Molecular targets in arthritis and recent trends in nanotherapy
por: Roy, Kislay, et al.
Publicado: (2015)

Strategies on Nanodiagnostics and Nanotherapies of the Three Common Cancers
por: Leng, Fan, et al.
Publicado: (2018)

Bioinspired and Biomimetic Nanotherapies for the Treatment of Infectious Diseases
por: Yang, Guoyu, et al.
Publicado: (2019)

Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability
por: Burke, Jacqueline A., et al.
Publicado: (2022)

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2023)

Nanotherapy for Cancer: Targeting and Multifunctionality in the Future of Cancer Therapies
por: Ediriwickrema, Asiri, et al.
Publicado: (2015)

Nanozyme-mediated catalytic nanotherapy for inflammatory bowel disease
por: Zhao, Jiulong, et al.
Publicado: (2019)

Energy Conversion-Based Nanotherapy for Rheumatoid Arthritis Treatment
por: Wang, Pingping, et al.
Publicado: (2020)

Transferrin: Biology and Use in Receptor-Targeted Nanotherapy of Gliomas
por: Koneru, Tejaswi, et al.
Publicado: (2021)

Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies
por: Del Genio, Valentina, et al.
Publicado: (2022)

Editorial for Special Issue “Cancer Treatment via Nanotherapy”
por: Wang, Lisheng
Publicado: (2023)

Nanocapsules modify membrane interaction of polymyxin B to enable safe systemic therapy of Gram-negative sepsis
por: Yuk, Simseok A., et al.
Publicado: (2021)

Improving nanotherapy delivery and action through image-guided systems pharmacology
por: Ng, Thomas S.C., et al.
Publicado: (2020)

COVID-19 transmission, vulnerability, persistence and nanotherapy: a review
por: Khan, Afzal Husain, et al.
Publicado: (2021)

Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy
por: Zhao, Yiming, et al.
Publicado: (2016)

Tumor Suppressor Gene-Based Nanotherapy: From Test Tube to the Clinic
por: Shanker, Manish, et al.
Publicado: (2011)

Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
por: Liu, Yang, et al.
Publicado: (2017)

Nano‐Enabled Reposition of Proton Pump Inhibitors for TLR Inhibition: Toward A New Targeted Nanotherapy for Acute Lung Injury
por: Sun, Liya, et al.
Publicado: (2021)

Oxygen‐Independent Sulfate Radical for Stimuli‐Responsive Tumor Nanotherapy
por: Ding, Dandan, et al.
Publicado: (2022)

Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies
por: Xu, Jiangmei, et al.
Publicado: (2022)

Designing Superoxide-Generating Quantum Dots for Selective Light-Activated Nanotherapy
por: Goodman, Samuel M., et al.
Publicado: (2018)

Nanotherapy and Reactive Oxygen Species (ROS) in Cancer: A Novel Perspective
por: Brenneisen, Peter, et al.
Publicado: (2018)

The exciting potential of nanotherapy in brain-tumor targeted drug delivery approaches
por: Agrahari, Vivek
Publicado: (2017)

The challenge of using nanotherapy during pregnancy: Technological aspects and biomedical implications
por: Pereira, Kelle Velasques, et al.
Publicado: (2020)

Bioresponsive nanotherapy for preventing dental caries by inhibiting multispecies cariogenic biofilms
por: Liu, Danfeng, et al.
Publicado: (2021)

Eosinophilic bioactivities in severe asthma
por: Carr, Tara F., et al.
Publicado: (2016)

Development of New Targeted Nanotherapy Combined with Magneto-Fluorescent Nanoparticles against Colorectal Cancer
por: Marcelo, Gonçalo A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6balb0aakqoekvbpcfis626bv2